Results 201 to 210 of about 37,019 (222)
Aquaporin-1 and Osmosis: From Physiology to Precision in Peritoneal Dialysis.
Devuyst O.
europepmc +1 more source
After ischemic stroke, TRPV4 activation induces cerebral edema through the TRPV4‐RhoA‐MMP9 axis: RhoA upregulates MMP9, which cleaves β‐DG to impair membrane anchoring. Subsequent β‐DG loss triggers AQP4 depolarization, disrupting GS‐mediated water homeostasis.
Yongchuan Li +13 more
wiley +1 more source
Abstract Objectives It is known that the benefit of intravenous methylprednisolone (IVMP) in multiple sclerosis‐related optic neuritis (MS‐ON) is limited to an accelerated recovery. We aimed to evaluate the impact of time from symptoms onset to IVMP initiation and of IVMP dose on visual recovery among people with MS‐ON.
Hadar Gilad +3 more
wiley +1 more source
Ontogeny of Aquaporins 1 and 3 in Ovine Placenta and Fetal Membranes
H. Johnston +8 more
openalex +2 more sources
Diagnosis and treatment of occipital brain lesions in children
Occipital brain lesions in children represent a diagnostic challenge due to the large spectrum of etiologies and overlapping clinical features. This review analyses common and less common causes of occipital brain lesions in children, including malformative, vascular, genetic/metabolic, infectious, inflammatory, and neoplastic conditions.
Luca Bartolini +4 more
wiley +1 more source
The Na<sup>+</sup>,K<sup>+</sup>,2Cl<sup>-</sup> Cotransporter, Not Aquaporin 1, Sustains Cerebrospinal Fluid Secretion While Controlling Brain K<sup>+</sup> Homeostasis. [PDF]
Jensen DB +12 more
europepmc +1 more source
ABSTRACT Introduction The degree of iodine clearance from the parenchyma in acute ischemic stroke (AIS) has not been determined. The aim of our study was to measure changes in cerebrospinal fluid (CSF) density in patients with AIS relative to controls.
Vadim Khasminsky +6 more
wiley +1 more source
Diagnostic accuracy of urinary aquaporin-1 as a biomarker for renal cell carcinoma.
Cheriyan A +6 more
europepmc +1 more source
The Therapeutic Potential of Cannabidiol in Skin Conditions
ABSTRACT Background Dermatological disorders can have a negative impact on quality of life. Cannabidiol (CBD) is a phytocannabinoid found in the Cannabis sativa L. plant. It has multiple molecular targets, many of which are expressed in the skin, and may have therapeutic potential in several skin conditions. Aims This review aims to provide an overview
Maria C. Redmond, David P. Finn
wiley +1 more source

